Position in LLY
as of Jun 30, 2026
· filed Jul 16, 2026
Position Value
$1,548,464
+$34,523 QoQ
Shares Held
1,291
-21.6% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.21%
of 13F equity value
Holder Rank
#2,737
of 4,605 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Violich Capital Management, Inc. holds $62,484,887 across 7 Drug Manufacturers - General names. LLY ranks #5 (2.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
109,254 | $27,492,676 | |
| 2 | JNJ |
Johnson & Johnson
|
87,990 | $22,346,820 | |
| 3 | MRK |
Merck & Co., Inc.
|
50,257 | $6,458,024 | |
| 4 | AMGN |
Amgen Inc
|
9,350 | $3,385,822 | |
| 5 | LLY |
ELI LILLY & Co
This page
|
1,291 | $1,548,464 | |
| 6 | PFE |
Pfizer Inc
|
26,350 | $634,508 | |
| 7 | NVS |
Novartis AG
|
3,947 | $618,573 |
All Filings in LLY
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,548,464 | 1,291 | Shares | Sole | 2026-07-16 | |
| 2026-03-31 | $1,513,941 | 1,646 | Shares | Sole | 2026-04-08 | |
| 2025-12-31 | $1,553,987 | 1,446 | Shares | Sole | 2026-02-03 | |
| No filing history on record for this holder in this stock. | ||||||